Cutaneous squamous cell carcinoma (SCC) of the head and neck: Risk factors of overall and recurrence-free survival

European Journal of Cancer

Volumn 46, Issue 9, 2010, Pages 1563-1572

  Kyrgidis, Athanassios ^a,b   Tzellos, Thrasivoulos George ^c   Kechagias, Nikolaos ^a   Patrikidou, Anna ^a   Xirou, Persa ^a   Kitikidou, Kyriaki ^d   Bourlidou, Eleni ^a   Vahtsevanos, Konstantinos ^a   Antoniades, Konstantinos ^a,c  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b AHEPA University Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Carcinoma; Head and neck; Inflammation; Metastasis; Perineural involvement; Recurrence; Skin; Squamous cell; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CAUCASIAN; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERINEURIUM; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; DISEASE FREE SURVIVAL; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; SECOND CANCER; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SKIN NEOPLASMS; KAPLAN-MEIER ESTIMATE;

EID: 77952584767     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.02.046     Document Type: Article

References (27)

1. Clayman G.L., Lee J.J., Holsinger F.C., et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 23 4 (2005) 759-765
2. Kyrgidis A, Tzellos D, Vahtsevanos K, Triaridis S. New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors and biomarkers. A systematic review of evidence regarding risk for tumour development, susceptibility for second primary and recurrence. J Surg Res 2009. doi:10.1016/j.jss.2008.11.834.
3. Kyrgidis A, Vahtsevanos K, Tzellos TG, et al. Clinical, histological and demographic predictors for recurrence and second primary tumour of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Eur J Dermatol, in press.
4. Oddone N., Morgan G.J., Palme C.E., et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 115 9 (2009) 1883-1891
5. Brantsch K.D., Meisner C., Schonfisch B., et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9 8 (2008) 713-720
6. Morselli P., Zollino I., Pinto V., Brunelli G., and Carinci F. Clinical prognostic factors in stage I head and neck squamous cell carcinoma. J Craniofac Surg 19 3 (2008) 740-743
7. Alam M., and Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 344 13 (2001) 975-983
8. Weinberg A.S., Ogle C.A., and Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 33 8 (2007) 885-899
9. Meadows A.T., Friedman D.L., Neglia J.P., et al. Second neoplasms in survivors of childhood cancer: findings from the childhood cancer survivor study cohort. J Clin Oncol 27 14 (2009) 2356-2362
10. Maghami E.G., Talbot S.G., Patel S.G., et al. Craniofacial surgery for nonmelanoma skin malignancy: report of an international collaborative study. Head Neck 29 12 (2007) 1136-1143
11. Veness M.J., Morgan G.J., Palme C.E., and Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 115 5 (2005) 870-875
12. In: Greene F., Page D., and Fleming I. (Eds). AJCC cancer staging handbook: TNM classification of malignant tumours. 6th ed. (2002), Springer, New York
13. Lip and Oral Cavity Cancer (PDQ®). In: Cancer topics. National Cancer Institute; 2009, http://www.cancer.gov/cancertopics/pdq/treatment/lip-and-oral-cavity/HealthProfessional/page2.
14. Weedon D., Morgan M.B., Gross C., Nagore E., and Yu L.L. Squamous cell carcinoma. In: LeBoit P.E., Burg G., and Weedon D.A.S. (Eds). Pathology and genetics of skin tumours (2006), IARC Press, Lyon
15. Liegeois N.J., Seo S.J., and Olbricht S. Squamous cell carcinoma. In: Williams H.C., Bigby M., Diepgen T.L., et al. (Eds). Evidence-based dermatology (2008), Blackwell Publishing, MA 248
16. Veness M.J., Palme C.E., and Morgan G.J. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 106 11 (2006) 2389-2396
17. Ross A.S., Whalen F.M., Elenitsas R., et al. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg 35 12 (2009) 1859-1866
18. Geist D.E., Garcia-Moliner M., Fitzek M.M., Cho H., and Rogers G.S. Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management. Dermatol Surg 34 12 (2008) 1642-1651
19. Lewis F.M., Shah M., Messenger A.G., and Thomas W.E. Metastatic squamous-cell carcinoma in patient receiving PUVA. Lancet 344 8930 (1994) 1157
20. Smoller B.R., and Warnke R.A. Cutaneous infiltrate of chronic lymphocytic leukemia and relationship to primary cutaneous epithelial neoplasms. J Cutan Pathol 25 3 (1998) 160-164
21. Maitland N.J., and Collins A.T. Inflammation as the primary aetiological agent of human prostate cancer: a stem cell connection?. J Cell Biochem 105 4 (2008) 931-939
22. Gonda T.A., Tu S., and Wang T.C. Chronic inflammation, the tumour microenvironment and carcinogenesis. Cell Cycle 8 13 (2009) 2005-2013
23. Alison M.R., Lim S., and Houghton J.M. Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship. Curr Opin Oncol 21 1 (2009) 77-82
24. Lorusso G., and Ruegg C. The tumour microenvironment and its contribution to tumour evolution toward metastasis. Histochem Cell Biol 130 6 (2008) 1091-1103
25. Herfs M., Hubert P., and Delvenne P. Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation?. Trends Mol Med 15 6 (2009) 245-253
26. Chao C., and Hellmich M.R. Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes (2009)
27. Ishizuka M., Nagata H., Takagi K., and Kubota K. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg 250 2 (2009) 268-272